← All recalls

GSK Consumer Health Recalls Five Excedrin Brands Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning

CPSC · 21057 · published 2020-12-23

CPSC campaign 21057

Hazard

Some of the bottles containing the over-the-counter drug can have a hole in the bottom. If there is a hole, children could access and swallow the contents, posing a risk of poisoning. These products contain the substances aspirin and acetaminophen which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA).

Remedy

Consumers should immediately store the recalled Excedrin bottles out of sight and reach of children and inspect the bottom of the bottle to determine if there is a hole. If there is a hole in the bottle, contact GSK Consumer Relations for information on how to receive a prepaid shipping label for return to receive a full refund. Bottles without a hole can be retained and used as directed.

The text above is quoted verbatim from the CPSC record. Confirm the affected units and the remedy with the manufacturer or CPSC. Recall data may be incomplete, delayed, or superseded.

Own something like this?

Track your items and we’ll tell you the moment a recall covers one — free, forever.

Track an item like this

Affected products

GSK Consumer Healthcare, of Warren, N.J.

Excedrin Migraine Caplets, Excedrin Migraine Geltabs, Excedrin Extra Strength Caplets, Excedrin PM Headache Caplets, and Excedrin Tension Headache Caplets

Brands in this recall